Anticoagulants for Atrial Fibrillation in Survivors of Intracranial Hemorrhage: A Meta-Analysis of Randomized Trials
- PMID: 40701674
- DOI: 10.1016/j.jacc.2025.04.069
Anticoagulants for Atrial Fibrillation in Survivors of Intracranial Hemorrhage: A Meta-Analysis of Randomized Trials
Keywords: anticoagulation; atrial fibrillation; intracranial hemorrhage; meta-analysis.
Conflict of interest statement
Funding Support and Author Disclosures Dr Damluji receives research funding from the Pepper Scholars Program of the Johns Hopkins University Claude D. Pepper Older Americans Independence Center funded by the National Institute on Aging P30-AG021334; a mentored patient–oriented research career development award from the National Heart, Lung, and Blood Institute (K23-HL153771); the NIH National Institute of Aging (R01-AG078153); and the Patient-Centered Outcomes Research Institute (PCORI). Dr Nanna receives research support from the American College of Cardiology Foundation, the Patient-Centered Outcomes Research Institute (PCORI), the Yale Claude D. Pepper Older Americans Independence Center (P30AG021342), and the National Institute on Aging (K76AG088428); and serves as a consultant for Novo Nordisk, Merck, and HeartFlow, Inc. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
LinkOut - more resources
Full Text Sources
